Compare iShares Global Tech ETF (IXN) vs Kymera Therapeutics Inc. Common Stock (KYMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares Global Tech ETF vs Kymera Therapeutics Inc. Common Stock — how do they compare? iShares Global Tech ETF trades at $140 (market cap $9.41B), while Kymera Therapeutics Inc. Common Stock trades at $106.81 (market cap $8.88B). The key difference: iShares Global Tech ETF and Kymera Therapeutics Inc. Common Stock are close in size by market cap, and iShares Global Tech ETF is more actively traded (655,816 versus 1,028,790). Which is the better fit depends on your goals — on Pluang, investors hold iShares Global Tech ETF for 48 Days and Kymera Therapeutics Inc. Common Stock for 0 Days on average.
| IXN | KYMR | |
|---|---|---|
Market Cap | $9.41B | $8.88B |
Volume | 655,816 | 1,028,790 |
Sector | Sector/Thematic | Health |
52-Week High | $152.94 | $127.31 |
52-Week Low | $95.76 | $55.80 |
Typical Hold Time | 48 Days | 0 Days |
Enterprise Value | — | $8.27B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IXN (iShares Global Tech ETF) trades at $147.07, down 0.49% on the day but maintains a bullish technical signal with strong moving average support. The ETF recently hit a 52-week high, reflecting momentum despite current consolidation. Technical indicators show mixed signals with neutral RSI readings but bearish ADX trends, while support levels cluster around $146-147.
The outlook remains constructive given the ETF's exposure to global technology leaders and attractive valuation metrics. Key risks include concentration in tech stocks and AI sector volatility. Analyst sentiment appears positive with recent buy ratings citing compelling valuations and long-term growth potential in the global tech landscape.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About iShares Global Tech ETF
IXN provides exposure to global electronics, software, and hardware companies. It tracks the S&P Global 1200 Information Technology Index, covering tech leaders across both developed and emerging markets.
Read more on IXN →About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →
